USPTO serial 79373992
RONOMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- KUHN, RIO NICE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RONOMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
FR
Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
FR
Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
FR
Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert J. Kenney
Robert J. Kenney Willcox & Savage, P.C.8201 Greensboro Drive, Suite 1001Attn.: IP AdministratorMcLean, VA 22102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceuticals sold on prescription, namely those treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; chemical preparations for pharmaceutical or medical use, namely for diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system; pharmaceutical preparations for combating the symptoms of Alzheimer's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for all means of administration, namely pharmaceutical preparations for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical solutions, gels and powders for all types of administration for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration; pharmaceutical solutions, gels and powders for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration | ACTIVE | — |
| 035 | Public relations; database management; establishing statistics in the nature of compilation of statistics for business or commercial purposes; sales promotions; organization of exhibitions for commercial and advertising purposes; organizing, managing, conducting exhibitions, fairs for advertising or commercial purposes; collection and systematization of data for business purposes in a central file in the field of pharmaceutical, health and medical research and development; retail store services or wholesale store services featuring pharmaceuticals products, pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system, pharmaceutical preparations for combating symptoms of Alzheimer's disease, pharmaceutical preparations for treating Alzheimer's disease, pharmaceutical solutions, gels and powders for all types of administration | ACTIVE | — |
| 042 | Medical research; biological research; scientific research for medical purposes in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; information with respect to medical and scientific research relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; providing laboratory research services in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; scientific research and development for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacology; research and development of medicines; scientific research in the field of galenics; preclinical studies and research; clinical studies and research; consultancy with respect to pharmacology | ACTIVE | — |
| 044 | Medical services; medical services relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; treating symptoms relating to central nervous system diseases and neurodegenerative diseases, namely, health care services for treating symptoms relating to central nervous diseases and neurodegenerative diseases; treating diseases of the central nervous system and neurodegenerative diseases, namely, health care services for treating diseases of the central nervous system and neurodegenerative diseases; treating Alzheimer's disease and its symptoms, namely, health care services for treating Alzheimer's disease and its symptoms; medical information services; providing medical information; providing information in the field of diagnosing and treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's, via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
- Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
- Other trademarks owned by COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS NORMANDIE UNIVERSITE
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RONOMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 23, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 23, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 12, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 15, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 14, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 23, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 22, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 18, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |